Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Lastly, we have a long history with HIMS both on the long side and the short. More recently, we...
— Paul Cerro
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Hims & Hers Health, Inc.
More institutional theses from Cedar Grove Capital Management
OneSpaWorld ($OSW) is an outsourced, asset-light provider of health, wellness, and spa services operating aboard international cruise ships and destination resorts. The manager re-entered...
Nektar Therapeutics ($NKTR) is a clinical biopharmaceutical firm developing rezpegaldesleukin (rezpeg) for autoimmune conditions, primarily atopic dermatitis and alopecia areata. The manager remains...
Evolv Technologies ($EVLV) provides AI-powered weapons-detection screening gateways for high-traffic environments, including schools, stadiums, and hospitals. Unlike conventional walkthrough...